UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Andersons Inc
ANDE
$2.22B
| $743K | ﹤0.01% |
30,309
| – | – |
|
|
CBPO
2077
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $741K | ﹤0.01% |
6,278
| – | – |
|
|
VAPO
2078
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $741K | ﹤0.01% |
3,450
+2,525
| +273% | +$563K |
|
2079
Mitek Systems
MITK
$834M
| $738K | ﹤0.01% |
41,500
| – | – |
|
2080
Axcelis
ACLS
$4.33B
| $737K | ﹤0.01% |
25,323
-3,346
| -12% | -$86.6K |
|
2081
Harmonic Inc
HLIT
$1.28B
| $737K | ﹤0.01% |
99,753
| – | – |
|
|
CMRC
2082
Commerce.com Inc Series 1
CMRC
$184M
| $735K | ﹤0.01% |
+11,461
| New | +$915K |
|
2083
Purple Innovation
PRPL
$41.7M
| $727K | ﹤0.01% |
+882
| New | +$643K |
|
|
QUOT
2084
DELISTED
Quotient Technology Inc
QUOT
| $725K | ﹤0.01% |
76,987
| – | – |
|
2085
Viking Therapeutics
VKTX
$4B
| $724K | ﹤0.01% |
128,640
+56,500
| +78% | +$342K |
|
|
CMO
2086
DELISTED
Capstead Mortgage Corp.
CMO
| $724K | ﹤0.01% |
124,597
+23,340
| +23% | +$133K |
|
2087
Preferred Bank
PFBC
$1.25B
| $724K | ﹤0.01% |
14,337
+1,661
| +13% | +$64.9K |
|
2088
Marten Transport
MRTN
$1.22B
| $723K | ﹤0.01% |
41,983
| – | – |
|
2089
Universal Electronics
UEIC
$61.3M
| $723K | ﹤0.01% |
13,784
+5,644
| +69% | +$261K |
|
2090
S&T Bancorp
STBA
$1.79B
| $722K | ﹤0.01% |
29,057
-4,296
| -13% | -$94.8K |
|
2091
Columbus McKinnon
CMCO
$584M
| $722K | ﹤0.01% |
18,773
| – | – |
|
2092
MarineMax
HZO
$788M
| $718K | ﹤0.01% |
20,484
+430
| +2% | +$13.5K |
|
2093
Axogen
AXGN
$2.5B
| $716K | ﹤0.01% |
40,020
-6,282
| -14% | -$92.3K |
|
|
MRC
2094
DELISTED
MRC Global
MRC
| $715K | ﹤0.01% |
107,857
+1,855
| +2% | +$10.2K |
|
|
RDUS
2095
DELISTED
Radius Health, Inc.
RDUS
| $715K | ﹤0.01% |
40,018
| – | – |
|
|
DMC
2096
Del Monte Corp
DMC
$1.45B
| $714K | ﹤0.01% |
29,682
-2,102
| -7% | -$50.7K |
|
2097
OneSpan
OSPN
$618M
| $712K | ﹤0.01% |
34,434
| – | – |
|
2098
Stock Yards Bancorp
SYBT
$2.6B
| $711K | ﹤0.01% |
17,575
| – | – |
|
2099
ACM Research
ACMR
$5.79B
| $710K | ﹤0.01% |
26,202
-3,000
| -10% | -$76.8K |
|
|
KDMN
2100
DELISTED
Kadmon Holdings, Inc.
KDMN
| $708K | ﹤0.01% |
170,620
+48,347
| +40% | +$191K |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.